Korea Information Service

Il Sung Pharm. Co.,Ltd. (003120)

STOCK


	(Unit : %, Times)

Fiscal Year End	2005.12.31	2006.12.31	2007.12.31	2008.12.31	2009. 9.30
Net Income to Total Assets	16.15	16.00	4.61	8.74	2.15
Ordinary Income to Total Assets	22.73	22.54	6.81	12.31	3.12
Operating Profit to Working Capital	17.25	22.84	26.85	25.65	25.65
Net Income to Equity	18.63	18.98	5.62	10.57	2.51
Net Income to Sales	36.49	49.03	22.45	42.77	9.71
Ordinary Income to Sales	51.36	69.08	33.13	60.25	14.07
Operating Income to Sales	25.83	26.86	25.94	22.83	16.48
Total Income to Sales	49.45	52.66	53.03	46.36	41.78
Times Interest earned	12,653.35	1,478.55	786.34	152.58	54.43
Financial Expenses/Sales	-	0.05	0.04	0.40	0.26
Equity to Total Assets	84.36	84.22	80.96	85.61	85.73
Liability to Equity	18.54	18.73	23.51	16.81	16.64
Borrowings & Bonds to Assets	-	-	-	-	0.85
Current Liabilities to Equity	13.36	9.65	2.82	7.48	3.18
Fixed Assets to Equity & L/T Liabilities	70.04	80.63	92.42	88.60	87.71
Fixed Ratio	73.66	87.95	111.54	96.86	99.52
Current Ratio	335.82	318.85	424.49	266.68	538.62
Quick Ratio	282.26	253.54	284.07	169.25	356.90
Debt Coverage Ratio	958,383.40	109,718.63	57,883.08	12,079.96	253.81
Total C/F to Liabilities	48.96	29.36	17.58	32.10	-
Business Capital Turn over	0.67	0.85	1.04	1.12	0.90
Total Assets Turn over	0.44	0.33	0.21	0.20	0.22
Trade Receivables Turn over	3.47	3.24	3.08	3.05	2.86
Inventories Turn over	6.10	5.80	5.19	4.73	4.00
Trade Payables Turn over	15.68	14.23	19.60	22.32	23.37
Sales Growth	7.97	1.82	0.32	1.32	- 11.95
Total Asset Growth	48.12	31.34	80.70	- 41.73	22.46
Equity Growth	38.66	31.13	73.71	- 38.39	22.63


	(Unit : %)


	(Unit : 100Mn. Won, %)